Details for New Drug Application (NDA): 088587
The generic ingredient in HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are four drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Summary for 088587
| Tradename: | HYDROCHLOROTHIAZIDE |
| Applicant: | Roxane |
| Ingredient: | hydrochlorothiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088587
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 2, 1984 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
